Mercaptoimidazoles as CCR2 receptor antagonists

Details for Australian Patent Application No. 2005250157 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Doyon, Julien Georges Pierre-Olivier; Coesemans, Erwin; Boeckx, Gustaaf Maria; Van Lommen, Guy Rosalia Eugeen

Agent Shelston IP

Pub. Number AU-A-2005250157

PCT Pub. Number WO2005/118574

Priority PCT/ EP2004/050935 26.05.04 EP

Filing date 24 May 2005

Wipo publication date 15 December 2005

International Classifications

C07D 233/84 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118574 Priority application(s): WO2005/118574

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250161-Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity

2005250156-Mercaptoimidazoles as CCR2 receptor antagonists